Advanced Nanocarriers for Enhanced Drug Safety, Stability, Bioavailability, and Therapeutic Effects

A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".

Deadline for manuscript submissions: 20 October 2024 | Viewed by 70

Special Issue Editor


E-Mail Website
Guest Editor
The Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
Interests: drug delivery; lipid nanoparticles; bioavailability; DSC; FTIR; dissolution; solubility; HPLC; separation; pharmaceutical analysis; LC–MS; proteomics; proteome
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Over the past few decades, a broad range of nanocarriers have been developed for the delivery of drugs in an effort to increase their solubility, absorption, bioavailability, stability, and therapeutic effects. They include micelles, nanoemulsions, liposomes, polymeric nanoparticles, lipid nanoparticles, nanostructured lipid carriers, and inorganic nanoparticles. Nanocarriers have been successfully used for various drug delivery applications, such as the delivery of small molecules, proteins, peptides, and genes, to treat many diseases. Currently, some drug-loaded nanocarriers have been approved for clinical use as nanomedicines.

Despite the advancement of nanomedicines in recent years, there is still a need to develop more of them to improve drug safety, stability, bioavailability, and therapeutic effects on different diseases. Alongside the bioavailability and therapeutic effects addressed in many studies, safety and stability are two critical aspects of nanocarriers that require in-depth investigation in preclinical studies.

In this Special Issue, we welcome reviews and original research on developing and characterizing nanocarriers for drug delivery, primarily focusing on improving drug safety, stability, bioavailability, and therapeutic effects. This includes, but is not limited to, the development and applications of nanocarriers for enhancing bioavailability and the treatment of various diseases; the investigation of the safety and stability of nanocarriers; and comprehensive reviews of drug, protein, or gene delivery advances using different types of nanocarriers.

Dr. Van-An Duong
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanocarrier
  • nanoparticles
  • bioavailability
  • lipid
  • polymer
  • pharmacokinetics
  • safety
  • stability

Published Papers

This special issue is now open for submission.
Back to TopTop